I-Arabinoxylan iyinkimbinkimbi ekhonjiswe egoboleni langaphandle lamahlamvu okusanhlamvu (njengokolweni kanye nelayisi). Ingxenye enkulu yefayibha yokudla etholakala okusanhlamvu okusanhlamvu, lesi sakhi sitholakala kwifomu lokugcwalisa ukudla. I-Arabinoxylan kuthiwa inikeza izinzuzo ezihlukahlukene zezempilo, kuhlanganise nokusebenza komzimba okuthuthukisiwe.
Ukusetshenziswa kwe-Arabinoxylan
Eminye imithi yokwelapha, i-arabinoxylan ifakwe njengendlela yokwelapha yemvelo yezimo zempilo ezilandelayo:
- i-asthma
- isifo esingapheliyo sokukhathala
- isifo sikashukela
- Isifo senhliziyo
- umfutho wegazi ophezulu
- i-cholesterol ephezulu
- ukukhuluphala
Ngaphezu kwalokho, i-arabinoxylan isetshenziselwa ukuvuselela amasosha omzimba kubantu abaphathwa ukwelashwa (okubandakanya i- chemotherapy ). Abanye abaxhasi bezokwelapha abengeziwe baphakamisa nokuthi i-arabinoxylan ingasiza ekulwa nomdlavuza.
I-Arabinoxylan nayo icatshangwa ukuthi iyasebenza njenge-prebiotic, uhlobo lwezinto ezikhuthaza ukukhula kwama- probiotics ( ama- bacteria azuzisayo aboniswe ekwandiseni impilo yegciwane nokuvuselela isimiso somzimba sokuzivikela).
Izinzuzo zezempilo ze-Arabinoxylan
Nakuba izifundo ezimbalwa ziye zahlolisisa ukusetshenziswa kwezithako zokudla eziqukethe i-arabinoxylan, kunobunye ubufakazi bokuthi i-arabinoxylan inganikeza izinzuzo eziningi zezempilo. Nakhu ukubuka okutholakala eziningana ku-arabinoxylan nemiphumela yayo yempilo:
1) Isifo sikashukela
I-Arabinoxylan ingasiza ukuphatha isifo sikashukela, ngokusho kwesifundo esincane esashicilelwe kuyi- European Journal of Clinical Nutrition ngo-2004.
Kulolu cwaningo, iziguli eziyi-15 zesifo sikashukela zenezela ukudla kwazo nge-arabinoxylan-enothile isinkwa nama-muffin noma ngesinkwa nama-muffins okwenziwa kuphela ngofulawa ogcwele ukolweni nomhlophe. Ngemuva kwamasonto amahlanu, amalungu okutadisha anikezwa isinkwa kanye nama-muffin e-arabinoxylan abonisa ukuthuthukiswa okukhulu kakhulu ekulawuleni ushukela egazini.
I-Arabinoxylan ingasiza ekulawuleni ishukela egazini kubantu abangenayo isifo sikashukela, iphakamisa isifundo esincane esanyatheliswa kuyi- American Journal of Clinical Nutrition ngo-2000. Ngemva kokudla ukudla kwasekuseni okuqukethe isinkwa esilusiwe i-arabinoxylan, amalungu atadisha atholakale anezixazululo eziphakeme kakhulu zoshukela egazini (uma kuqhathaniswa lapho bebedla isidlo sasekuseni esingenalo isinkwa esilusizo sama-arabinoxylan). Ucwaningo lwafaka abahlanganyeli abangu-14 abaphilile.
2) Impilo yezondlo
Ucwaningo olwanyatheliswa kuyi- British Journal of Nutrition ngo-2012 lubonisa ukuthi i-arabinoxylan ingasiza ekuthuthukiseni impilo enhle. Esivivinyweni somtholampilo esibandakanya abantu abadala abadala abanempilo engama-63, abalobi bezocwaningo bathi ukudla amagremu ayi-10 e-arabinoxylan-aphuca ukolweni wengqolowa nsuku zonke emasontweni amathathu kwahlanganiswa nokuthuthukiswa kwamakaki amaningana empilo yesisu, kuhlanganise nokwehla emvuthweni wokuvela kwesibindi.
3) Ukukhuluphala
Ucwaningo lokuqala luveza ukuthi i-arabinoxylan ingaba nemiphumela yokulwa nokukhuluphala. Esifundweni sika-2011 eshicilelwe ku- PLoS One , isibonelo, izinja ezondla ukudla okunomsoco we-arabinoxylan zathola ukwehla kwamathambo amafutha nokuzuza kwesisindo. I-Arabinoxylan nayo yabonakala ukusiza i-cholesterol ephansi, ukunciphisa ukuvuvukala , nokuthuthukisa ukuzwela kwe-insulin .
Kodwa-ke, okwamanje aziwa ukuthi i-arabinoxylan ingasiza ekulwa nokukhuluphala kubantu.
4) Igciwane
I-Arabinoxylan ibonisa isithembiso ekwelapheni ezinye izinhlobo zomdlavuza. Ngokwesibonelo, isifundo eshicilelwe ku- Anticancer Research ngo-2010 sathola ukuthi inhlanganisela ye-arabinoxylan kanye ne-interventional therapy ehilela i-chemotherapy yayizuzisa ekwelapheni i-hepatocellular carcinoma. Uma kuqhathaniswa namalungu okutadisha anikezwa ukwelashwa okungenelela kuphela, labo abelwe ukuhlanganiswa kokwelapha babe nokuphindaphinda kwesifo, izinga eliphakeme lokusinda, nokunciphisa okukhulu kwevolumu.
Isivivinyo somtholampilo eside iminyaka emithathu sineziguli ezingu-68.
Kubalulekile ukuqaphela ukuthi ucwaningo olwengeziwe luyadingeka ngaphambi kokuba i-arabinoxylan inganconywa ekwelapheni kwanoma yiluphi uhlobo lomdlavuza.
Amapulangwe
Idatha yokuphepha ekusetshenzisweni kwesikhathi eside noma ejwayelekile ye-arabinoxylan okwamanje ayikho. Kodwa-ke, njengoba i-arabinoxylan ingase ihlehlise amazinga kashukela egazi, kunokukhathazeka okuthile ukuthi ukusebenzisa i-arabinoxylan ngokuhambisana nemithi yesifo sikashukela kungaba nemiphumela emibi.
Khumbula ukuthi ama-supplements awazange ahlolwe ukuphepha kanye nezindleko zokudla ngokuyinhloko ezingavunyelwe ngokomthetho. Kwezinye izimo, umkhiqizo ungase ulethe ukulinganisa okungafani nesilinganiso esicacisiwe semifino ngayinye. Kwezinye izimo, umkhiqizo ungangcoliswa nezinye izinto ezifana nezensimbi. Futhi, ukuphepha kwezidakamizwa kwabesifazane abakhulelwe, omama abahlengikazi, izingane, nalabo abanezimo zezokwelapha noma abaphuza imishanguzo azange zisungulwe. Ungathola amathiphu engeziwe okusebenzisa izithako lapha .
Lapho Uzoyithola khona
Izithako zokudla eziqukethe i-arabinoxylan zithengiswa kwezinye izitolo zokudla zemvelo, izidakamizwa nezitolo ezikhethekile imikhiqizo yemvelo. Ungathenga futhi i-arabinoxylan online.
Ukusebenzisa i-Arabinoxylan yezeMpilo
Ngenxa yokucwaninga okulinganiselwe, kusheshe kakhulu ukutusa i-arabinoxylan ekuvimbeleni noma ekwelapheni kwanoma yisiphi isimo. Kubalulekile ukuqaphela ukuthi ukuzitholela isimo futhi ukugwema noma ukubambezela ukunakekelwa okujwayelekile kungaba nemiphumela emibi. Uma ucabangela ukusebenzisa i-arabinoxylan nganoma iyiphi injongo yezempilo, qiniseka ukuthi uqale uthintane nodokotela wakho kuqala.
> Imithombo:
> Bang MH, Van Riep T, Thinh NT, Song le H, Dung TT, Van Truong L, Van Don L, Ky TD, Pan D, Shaheen M, Ghoneum M. "I-Arabhuinoxylan Ipulazi Yensimu (MGN-3) Ithuthukisa Imiphumela I-Treatment Interventional for the Treatment of Hepatocellular Carcinoma: Isivivinyo Sokutholwa Kweminyaka Emithathu Elandelwayo. " I-Anticancer Res. 2010 Dec; 30 (12): 5145-51.
> Broekaert WF, Courtin CM, Verbeke K, Van de Wiele T, Verstraete W, Delcour JA. "I-Prebiotic Nezinye Imiphumela Ehlobene Nezempilo-I-Arabinoxylans, E-Arabinoxylan-Oligosaccharides, ne-Xylooligosaccharides." Crit Rev Rev Food Sci Nutr. 2011 Feb; 51 (2): 178-94.
> François IE, Lescroart O, Veraverbeke WS, Marzorati M, Possemiers S, Evenepoel P, Hamer H, Houben E, Windey K, Welling GW, Delcour JA, Courtin CM, Verbeke K, Broekaert WF. "Imiphumela ye-Branct Extract Ephethe ama-Oligosaccharides e-Arabhuinoxylan Emiphakathini Yezempilo Yezinsizakalo Emitholampilo Yabantu Abadala Abanempilo: I-Double-Blind, Randomized, Placebo-Controlled, Cross-Over Trial." Br J Nutriti. 2012 Dec 28; 108 (12): 2229-42.
> Lu ZX, Walker KZ, Muir JG, Mascara T, O'Dea K. "I-Arabinoxylan Fiber, i-Byproduct of Wheat Flour Processing, iyanciphisa ukuphendula kweGlucose yePostprandial ngezihloko ze-Normoglycemic." I-Am J Clin Nutr. 2000 Meyi; 71 (5): 1123-8.
> Lu ZX, Walker KZ, Muir JG, O'Dea K. "I-Arabinoxylan Fiber Ithuthukisa Ukulawulwa Kwemetaboliki Kubantu Abahlobo Lwesifo Sikashukela." I-Eur J Clin Nutriti. 2004 Apr; 58 (4): 621-8.
> Neyrinck AM, Abakwa-S, Abakwa-C, Van de Wiele T, i-De Backer F, iCani PD, uLarondelle Y, i-Delzenne NM. "Imiphumela ye-Prebiotic ye-Wheat Arabinoxylan Ehlobene Nokunyuka Kwe-Bifidobacteria, i-Roseburia ne-Bacteroides / Prevotella kuma-Amese aphethwe ngokudla." PLoS One. 2011; 6 (6): e20944.